MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'breaks'. Sat, 03 Sep 2011 02:33:06 +0100 http://www.medworm.com/index.php?rid=4813251&cid=t_284110_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FZt5mv_FnBa4%2F By Jason KuznickiThe media makes it hard for ordinary people to be libertarians. In large part, this is because journalism is in the business of selling panic—panic about terrorism, panic about drugs, panic about food, panic about pornography, panic about our health care system. If it’s not an emergency, it’s not news. To the lazy journalist, everything becomes an emergency—and emergencies always—always—demand state action. The media makes things hard for the would-be libertarian in other ways, too. Consider this story from today’s Washington Post, about… well, it’s hard to say, actually: Senate Democrats unveiled a plan Tuesday to save $21 billion over the next decade by eliminating tax breaks for the nation’s five biggest oil companies, a move desi... Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=4813251 Wed, 11 May 2011 15:02:07 +0100 4813251 http://www.medworm.com/index.php?rid=4723943&cid=t_284110_109_f&fid=34750&url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2011%2F04%2F17%2Ffeeling-anxious-here-are-3-iphone-apps-to-help-you-relax%2F Photo credit: Helga Weber Digital distractions are everywhere. You’re only two sentences into this blog post, but I’ll bet you’re already thinking about switching tabs to see if you have any comments on that new Facebook wall post you just made. Now you’ve reached the second paragraph, and I know you want to — have to, in fact — refresh your Gmail just one more time. Or check your @replies on Twitter, again, just like you did five minutes ago. Or pull up Reddit, again, hoping to see that red/orange envelope all lit up to notify you of a brand new message. Wait — did you hear something vibrate from across the room? Was it your phone? Maybe you should go and check your texts. Technology can scatter our attention into about a million directions at onc... World of Psychology blogs http://www.medworm.com/rss/comments.php?id=4723943 Sun, 17 Apr 2011 21:49:00 +0100 4723943 http://www.medworm.com/index.php?rid=4507582&cid=t_284110_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fjhk8uLvM9QY%2F Call it congressional deja vu. Last week, a pair of bills that previously went nowhere were again introduced and both take aim at brand-name drugmakers. The first, called the Say No to Drug Ads Act, would eliminate tax breaks for direct-to-consumer advertising and was introduced by Jerry Nadler, a Democratic Congressman from New York who failed to enlist any co-sponsors. The rationale for his repeat effort is that DTC ads allow drugmakers to “keep prices artificially high, steering consumers – and physicians – away from generics…It’s bad enough that TV drug ads mislead consumers and tout benefits of high-priced drugs without properly conveying the risks, but the drug companies don’t need extra subsidies to do so,” he says in a statement. (You can read the bill her... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4507582 Tue, 22 Feb 2011 13:27:06 +0100 4507582 http://www.medworm.com/index.php?rid=4337905&cid=t_284110_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FyqkZIb7nJXU%2F By Michael F. CannonThe Center for American Progress has a new weekly feature examining “tax expenditures” in the Internal Revenue Code.  As I’ve written before, there ain’t no such thing as a tax expenditure. Or a tax subsidy.  Targeted tax breaks are bad because, on balance, they expand government’s control over the people.  But they are not “expenditures” or “subsidies.”  Using either of those terms implies that the money not collected by the IRS because of a targeted tax break actually belongs to the federal government, rather than the people who earned it. The Left would love to convince everyone that, as the Center for American Progress writes, “Tax expenditures are really just federal spending programs administered by... Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=4337905 Wed, 12 Jan 2011 23:28:02 +0100 4337905 http://www.medworm.com/index.php?rid=4179307&cid=t_284110_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FIy0VAwXbGjc%2F By Michael F. CannonI hit a nerve with my post, “There Ain’t No Such Thing as a Tax Expenditure.”  To recap: The federal tax code has credits, deductions, exemptions, and exclusions that reduce tax revenue.  By convention, budget experts call that forgone revenue a “tax expenditure,” a “tax subsidy,” or even “backdoor spending in the tax code.”  This is incorrect.  To claim that forgone tax revenue is a government expenditure implies that the money at stake actually belongs to the government, which is graciously letting taxpayers keep it, rather than to the people who earned it.  Government is not spending that money; it is merely not extracting that money from the private sector.  Statists deliberately use terms like “tax ... Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=4179307 Thu, 18 Nov 2010 19:25:08 +0100 4179307 http://www.medworm.com/index.php?rid=4164519&cid=t_284110_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FQhtvYHK4SLE%2F By David BoazMuch of the media discussion of the massive tax increase that looms on January 1 uses terms like “extending the Bush tax cuts” or “tax breaks for the wealthy.” In fact, American taxpayers have faced a particular range of personal income tax rates for the past eight years. If the 2001 and 2003 tax laws are allowed to expire, then Americans will see increased tax rates on income, dividends, capital gains, and estates. So the issue is not “tax cuts” or “tax breaks,” it’s whether we should increase taxes in 2011. It’s good to see that President Obama understands this. At a news conference at the end of the G-20 Summit on Friday, he said: I want to make sure that taxes don’t go up for middle class families starting o... Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=4164519 Sat, 13 Nov 2010 21:10:48 +0100 4164519 http://www.medworm.com/index.php?rid=3965396&cid=t_284110_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FIcm7T-_dWWs%2F By Daniel GriswoldIn the 2006 and 2008 election cycles, Republican candidates for Congress tried to save their bacon by running against immigration. In 2010, according to the Wall Street Journal this morning, a number of Democrats are trying to save their seats by running against trade. I predict the Democratic tactic will be as fruitless as the Republican effort before it. Democratic incumbents have been running TV ads accusing their Republican challengers of favoring trade agreements, outsourcing, and tax breaks for U.S. companies that invest abroad. The charges are wrong on substance, as I address at length in my 2009 Cato book Mad about Trade: Why Main Street America Should Embrace Globalization, but running against trade has not proven to be a vote getter, either. It is difficult to f... Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=3965396 Mon, 13 Sep 2010 16:11:00 +0100 3965396 http://www.medworm.com/index.php?rid=3767315&cid=t_284110_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FUPI_dkTAal8%2F Now that Pfizer has decided to keep an R&D facility and about 300 jobs in Richmond, Virginia, the city may give the drugmaker $650,000 in tax grants over a 10-year period, starting in 2014. Although the grant would be capped, Pfizer would be able to request additional funds for every $50 million invested in the property. “It’s a performance-based grant - very modest,” Peter Chapman, deputy chief administrative officer for economic and community development, tells The Richmond Times-Dispatch, who adds the tax break is critical to hold on to the jobs. Such incentives, which some decry as corporate welfare, are regularly used to encourage companies to relocate or retain jobs, although results don’t always match expectations. Two years ago, the widely used practic... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3767315 Mon, 19 Jul 2010 11:46:08 +0100 3767315 http://www.medworm.com/index.php?rid=3552546&cid=t_284110_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fu5xnfU-IeWo%2F Seven years after receiving millions of dollars in tax breaks to create jobs in New York, Pfizer is eliminating up to 1,400 workers amid a vast consolidation that was accelerated by its $68 billion purchase last year of Wyeth. Along with the cuts and musical job chairs, which come on top of 2,000 other positions already eliminated, the drugmaker is also putting a midtown office building up for sale, The New York Times notes. Pfizer will retain its midtown headquarters on East 42nd Street, as well as 4,400 employees, but now faces an angry and embarassed Bloomberg administration, which wants to recover twice the $12 million in tax breaks awarded in 2003. A spokesman for the city’s Economic Development Corporation tells the paper the city can pursue twice the amount of breaks if Pfizer... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3552546 Tue, 11 May 2010 12:14:43 +0100 3552546 http://www.medworm.com/index.php?rid=3079579&cid=t_284110_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FK2VTT1265iM%2F Just how much? About $490 million that would be used to develop and make new meds unless the UK government quickly puts in place some new tax breaks. Glaxo likes the planned tax incentives on income from patents, but warned these should apply to drugs already under development, The Financial Times writes. The UK’s Department for Business, Innovation and Skills, however, claims policies announced this week by Alistair Darling, the chancellor of the exchequer, were “already delivering major investment decisions,” and made a point of noting more than $800 million in investments planned by Glaxo (see the statement). But there’s a bit of disagreement. In its own statement, Glaxo indicated that a $325 million for production of new respiratory meds had already been planned for its... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3079579 Fri, 11 Dec 2009 13:22:51 +0100 3079579 http://www.medworm.com/index.php?rid=2989409&cid=t_284110_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FfwMa_oLZ8dU%2F And so another work week is drawing to a close. And not a moment too soon, yes? What will you do this weekend? Our favorite sport is raking leaves - the exercise is worth the effort. Of course, there are errands to run and keeping up with the short and not-so-short people is a favorite pre-occupation. Meanwhile, though, today beckons. So time to get moving. Have a nice weekend, everyone… Pfizer May Have To Repay Missouri Tax Breaks (St.LouisToday) Cephalon And Barr Settle Fentora Patent Dispute (Reuters) Abbott Grabs Experimental Pain Drug (Chicago Tribune) (Source: Pharmalot) Pharmalot blogs http://www.medworm.com/rss/comments.php?id=2989409 Fri, 13 Nov 2009 13:04:41 +0100 2989409 http://www.medworm.com/index.php?rid=3105026&cid=t_284110_97_f&fid=35606&url=http%3A%2F%2Ftheangriestpharmacist.com%2F2009%2F08%2F30%2Fpharmacy-optimization-with-enterprise-re-engineering-my-disdain-thoughts-and-call-to-arms%2F P.O.W.E.R. — (n. – ENG) Pharmacy Optimization With Enterprise Re-engineering. It’s okay. It hasn’t hit my area yet, but my fellow citizens aren’t stupid. They are asking what it is, what my thoughts are, and what they should do. [Again, you have my word that I do *NOT* work for Walgreens -- at all...] Anyway, my marquee is exactly as I said it would be (Yes, heart included): Your Rx Filled RIGHT HERE by OUR Pharmacist ♥ It’s going over good. Some people know and they like it. Others don’t know and they ask…so I’m starting the word of mouth of all the rumblings and grumblings. All the fodder I need is on the Student-Doctor Network or other various message boards. Everyone has a problem. No one has stated, supported, backed, and pushed ... The Angriest Pharmacist blogs http://www.medworm.com/rss/comments.php?id=3105026 Sun, 30 Aug 2009 08:32:23 +0100 3105026 http://www.medworm.com/index.php?rid=2021338&cid=t_284110_125_f&fid=34820&url=http%3A%2F%2Fwww.dentalblogs.com%2Farchives%2Fadministrator%2Fdentists-should-make-the-most-of-tax-breaks-in-2008%2F While we can’t be sure what the economy holds or who will go to the Super Bowl, two things are certain: death and taxes. The bad news is, no matter what, you’ll have to file and you’ll have to pay. The good new is, this year you can get some great breaks on large purchases of dental equipment and technology. Before you go to your CPA, check out these resourceful articles to boost your tax IQ: “The breakdown on new equipment and taxes,” by Noah Levine, Dental Products Report “On Target: An Exclusive DentalBlogs Interview with Keith Drayer of Henry Schein Financial Services” (see question eight) “Tax losses: another benefit of the bear market,” by Gene Dongieux, Dental Economics (off topic, good info) “New Tax Legislation Could Sav... dental blog for dentists about dentistry blogs http://www.medworm.com/rss/comments.php?id=2021338 Mon, 08 Dec 2008 20:05:37 +0100 2021338 http://www.medworm.com/index.php?rid=1851211&cid=t_284110_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F409395623%2F Rahm Emanuel, an Illinois Democrat, warned advertising industry leaders that the business-tax deduction for DTC spending could be taken away in 2009 tax legislation, according to DTC Perspectives. In a recent meeting with the government affairs committee of the American Association of Advertising Agencies, the newsletter writes Emanuel presented two options for pharma in new tax legislation: retain the tax credit for R&D spending, or keep the business expense deduction for DTC ads - but not both. “He said this without any tinge of satire, so you have to accept him at his word,” one ad industry advocate familiar with the meeting tells DTC Perspectives, which claims an average drugmaker spends roughly 10 times more on R&D each year than on consumer promotion (although we recal... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1851211 Thu, 02 Oct 2008 16:26:22 +0100 1851211 http://www.medworm.com/index.php?rid=1347623&cid=t_284110_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F263262514%2F Tax incentives used to lure - and more often keep - companies within state borders have always been controversial. New Jersey, however, has been particularly vulnerable over the past decade, because so many big drugmakers have global or US headquarters or large facilities in the Garden State and, for years, opined about building labs or factories in cheaper climes or locales where world-class teaching hospitals could be found, such as Boston. So New Jersey officials regularly ponied up. But one wag says the effort is a waste, and cites three familiar names - Bristol-Myers Squibb, Pfizer and Novartis collectively received more than $65 million in subsidies from New Jersey, but are now laying off employees and reducing their business. And so in an editorial in The Star-Ledger of New Jersey, ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1347623 Thu, 03 Apr 2008 11:08:33 +0100 1347623 http://www.medworm.com/index.php?rid=1280997&cid=t_284110_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F246101184%2F Last year, Pfizer announced it was laying off 600 workers and ending production at the historic Brooklyn factory where the company was founded back in 1849. The last employee at the Williamsburg plant will be gone by the end of this year. Yet, writes a columnist for The New York Daily News, the drugmaker is milking New York City for lucrative tax breaks by promising to create jobs - only to turn around and cut its workforce. Four years ago, Pfizer signed an agreement for nearly $10 million in tax breaks with the administration of Mayor Michael Bloomberg. In return, the company promised to increase total employment at its Manhattan headquarters and its Brooklyn plant (see photo) from 5,735 to 8,659. In 2004 alone, the first year of the agreement, Pfizer was supposed to add 1,000 jobs, colu... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1280997 Wed, 05 Mar 2008 12:42:06 +0100 1280997 http://www.medworm.com/index.php?rid=754204&cid=t_284110_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F136814704%2F Two years ago, when companies received a big tax break to bring home their offshore profits, the president and Congress justified it as a one-time tax amnesty that would create American jobs. Drugmakers were the biggest beneficiaries of the program, repatriating about $100 billion in foreign profits and paying only minimal taxes, The New York Times reports. But pharma didn’t create many jobs in return. Instead, since 2005 the US industry has laid off tens of thousands of workers in this country. And now, the Times writes, drugmakers are once again using complex strategies, many of them demonstrably legal, to shelter billions of dollars in profits in international tax havens, according to their financial statements and independent tax experts. In one popular accounting move, companies... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=754204 Tue, 24 Jul 2007 10:54:28 +0100 754204 http://www.medworm.com/index.php?rid=478755&cid=t_284110_87_f&fid=34867&url=http%3A%2F%2Fwww.thediabetesblog.com%2F2007%2F03%2F06%2Fthe-first-urine-test-to-detect-insulin-doping-in-athletes%2F Filed under: Type 1, Type 2, Childhood, Adult Onset, Lifestyle, Drugs, SupportScientists in Germany are reporting development of a urine test that finally can identify athletes who misuse certain kinds of insulin in an illicit attempt to enhance performance. An article scheduled to appear in an April edition of Analytical Chemistry says it is possible to detect the misuse of insulin in a urine sample. Scientists had not attempted to develop a test in the past because of the presumption that it was impossible to detect misuses of insulin. Because insulin is rationed and used efficiently by the body, a byproduct of insulin would be theoretically undetectable. However, with the advent of the newer long-acting insulin analogues, scientists are now able to identify degradation product in the ur... The Diabetes Blog blogs http://www.medworm.com/rss/comments.php?id=478755 Tue, 06 Mar 2007 05:00:00 +0100 478755